Cancer gene therapy using mesenchymal stem cells

作者: Ryosuke Uchibori , Tomonori Tsukahara , Ken Ohmine , Keiya Ozawa

DOI: 10.1007/S12185-014-1537-7

关键词:

摘要: Cellular and gene therapies represent promising treatment strategies at the frontier of medicine. Hematopoietic stem cells, lymphocytes, mesenchymal cells (MSCs) can all serve as sources for use in such therapies. Strategies therapy are often based on those cell therapy, it is anticipated that some examples will be put to practical near future. Given their ability support hematopoiesis, MSCs may useful enhancement engraftment, acceleration hematopoietic reconstitution. Furthermore, advance severe graft-versus-host disease, immunosuppressive ability. This application also homing behavior sites injury inflammation. Interestingly, possess tumor-homing ability, opening up possibility applications targeted delivery anti-cancer genes tumors. Many reports have indicated utilized target tumors deliver molecules locally, recognized non-healing wounds with inflammatory tissue. Here, we review both potential cellular vehicles cancer molecular mechanisms underlying MSC accumulation tumor sites.

参考文章(50)
Alexander Shpektor, Cardiogenic shock: the role of inflammation. Acute Cardiac Care. ,vol. 12, pp. 115- 118 ,(2010) , 10.3109/17482941.2010.523705
Marek Honczarenko, Yi Le, Marcin Swierkowski, Ionita Ghiran, Aleksandra M. Glodek, Leslie E. Silberstein, Human Bone Marrow Stromal Cells Express a Distinct Set of Biologically Functional Chemokine Receptors Stem Cells. ,vol. 24, pp. 1030- 1041 ,(2006) , 10.1634/STEMCELLS.2005-0319
Simon R. Bababeygy, Samuel H. Cheshier, Lewis C. Hou, Dominique M.O. Higgins, Irving L. Weissman, Victor C.K. Tse, Hematopoietic stem cell-derived pericytic cells in brain tumor angio-architecture. Stem Cells and Development. ,vol. 17, pp. 11- 18 ,(2008) , 10.1089/SCD.2007.0117
Y Wu, B P Zhou, TNF-α/NF-κB/Snail pathway in cancer cell migration and invasion British Journal of Cancer. ,vol. 102, pp. 639- 644 ,(2010) , 10.1038/SJ.BJC.6605530
Laura E. Benjamin, Dragan Golijanin, Ahuva Itin, Dov Pode, Eli Keshet, Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal Journal of Clinical Investigation. ,vol. 103, pp. 159- 165 ,(1999) , 10.1172/JCI5028
Lucia Kucerova, Miroslava Matuskova, Andrea Pastorakova, Silvia Tyciakova, Jana Jakubikova, Roman Bohovic, Veronika Altanerova, Cestmir Altaner, Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice The Journal of Gene Medicine. ,vol. 10, pp. 1071- 1082 ,(2008) , 10.1002/JGM.1239
L. S. Sasportas, R. Kasmieh, H. Wakimoto, S. Hingtgen, J. A. J. M. van de Water, G. Mohapatra, J. L. Figueiredo, R. L. Martuza, R. Weissleder, K. Shah, Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy Proceedings of the National Academy of Sciences of the United States of America. ,vol. 106, pp. 4822- 4827 ,(2009) , 10.1073/PNAS.0806647106
Tanja Hakkarainen, Merja Särkioja, Petri Lehenkari, Susanna Miettinen, Timo Ylikomi, Riitta Suuronen, Renee A. Desmond, Anna Kanerva, Akseli Hemminki, Human mesenchymal stem cells lack tumor tropism but enhance the antitumor activity of oncolytic adenoviruses in orthotopic lung and breast tumors. Human Gene Therapy. ,vol. 18, pp. 627- 641 ,(2007) , 10.1089/HUM.2007.034
Xiancheng Chen, Xiaojuan Lin, Jianlei Zhao, Wei Shi, Heng Zhang, Yongsheng Wang, Bing Kan, Licheng Du, Baiding Wang, Yuquan Wei, Yi Liu, Xia Zhao, None, A Tumor-selective Biotherapy With Prolonged Impact on Established Metastases Based on Cytokine Gene-engineered MSCs Molecular Therapy. ,vol. 16, pp. 749- 756 ,(2008) , 10.1038/MT.2008.3
John E. Levine, Implications of TNF-α in the pathogenesis and management of GVHD International Journal of Hematology. ,vol. 93, pp. 571- 577 ,(2011) , 10.1007/S12185-011-0803-1